204 related articles for article (PubMed ID: 15309911)
1. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme.
Shinojima N; Kochi M; Hamada J; Nakamura H; Yano S; Makino K; Tsuiki H; Tada K; Kuratsu J; Ishimaru Y; Ushio Y
J Neurosurg; 2004 Aug; 101(2):219-26. PubMed ID: 15309911
[TBL] [Abstract][Full Text] [Related]
2. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.
Shinoda J; Sakai N; Murase S; Yano H; Matsuhisa T; Funakoshi T
J Neurooncol; 2001 Apr; 52(2):161-71. PubMed ID: 11508816
[TBL] [Abstract][Full Text] [Related]
3. Radical surgery and reoperation in supratentorial malignant glial tumors.
Daneyemez M; Gezen F; Canakçi Z; Kahraman S
Minim Invasive Neurosurg; 1998 Dec; 41(4):209-13. PubMed ID: 9932265
[TBL] [Abstract][Full Text] [Related]
4. Outcome and prognostic factors in adult cerebellar glioblastoma.
Babu R; Sharma R; Karikari IO; Owens TR; Friedman AH; Adamson C
J Clin Neurosci; 2013 Aug; 20(8):1117-21. PubMed ID: 23706183
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
[TBL] [Abstract][Full Text] [Related]
6. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study.
Scott JN; Rewcastle NB; Brasher PM; Fulton D; MacKinnon JA; Hamilton M; Cairncross JG; Forsyth P
Ann Neurol; 1999 Aug; 46(2):183-8. PubMed ID: 10443883
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
8. Key determinants of short-term and long-term glioblastoma survival: a 14-year retrospective study of patients from the Hermelin Brain Tumor Center at Henry Ford Hospital.
Mazaris P; Hong X; Altshuler D; Schultz L; Poisson LM; Jain R; Mikkelsen T; Rosenblum M; Kalkanis S
Clin Neurol Neurosurg; 2014 May; 120():103-12. PubMed ID: 24731587
[TBL] [Abstract][Full Text] [Related]
9. Socioeconomic and educational factors interference in the prognosis for glioblastoma multiform.
Lynch JC; Welling L; Escosteguy C; Pereira AG; Andrade R; Pereira C
Br J Neurosurg; 2013 Feb; 27(1):80-3. PubMed ID: 22900509
[TBL] [Abstract][Full Text] [Related]
10. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.
Mohan DS; Suh JH; Phan JL; Kupelian PA; Cohen BH; Barnett GH
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):981-7. PubMed ID: 9869219
[TBL] [Abstract][Full Text] [Related]
11. Do Long-Term Survivor Primary Glioblastoma Patients Harbor IDH1 Mutations?
Sarmiento JM; Mukherjee D; Black KL; Fan X; Hu JL; Nuno MA; Patil CG
J Neurol Surg A Cent Eur Neurosurg; 2016 May; 77(3):195-200. PubMed ID: 26935296
[TBL] [Abstract][Full Text] [Related]
12. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
[TBL] [Abstract][Full Text] [Related]
13. [Supratentorial glioma: analysis of clinical and temporal parameters in 163 cases].
Huber A; Beran H; Becherer A; Prosenc N; Witzmann A
Neurochirurgia (Stuttg); 1993 Nov; 36(6):189-93. PubMed ID: 8309494
[TBL] [Abstract][Full Text] [Related]
14. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
16. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?
McLendon RE; Halperin EC
Cancer; 2003 Oct; 98(8):1745-8. PubMed ID: 14534892
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of primary cerebellar glioblastoma multiforme in adults.
Gopalakrishnan CV; Dhakoji A; Nair S; Menon G; Neelima R
J Clin Neurosci; 2012 Dec; 19(12):1684-8. PubMed ID: 23084346
[TBL] [Abstract][Full Text] [Related]
18. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
Mizumoto M; Tsuboi K; Igaki H; Yamamoto T; Takano S; Oshiro Y; Hayashi Y; Hashii H; Kanemoto A; Nakayama H; Sugahara S; Sakurai H; Matsumura A; Tokuuye K
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):98-105. PubMed ID: 19695794
[TBL] [Abstract][Full Text] [Related]
20. Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression.
Mu L; Wang Y; Wang Y; Zhang H; Shang D; Tan F; Li Y; Chen X
World Neurosurg; 2017 Jan; 97():279-283. PubMed ID: 27744078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
